MedPath

Clinical Study for Xuefu Zhuyu Capsule on Chest Pain after Thoracic Pneumonectomy in Early Stage Non-small Cell Lung Cancer

Phase 4
Conditions
on-small cell lung cancer
Registration Number
ITMCTR1900002480
Lead Sponsor
Peking University People's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Patients underwent thoracoscopic sublobar, lobe, composite lobectomy or pneumonectomy with or without mediastinal lymph node dissection; postoperative pathological diagnosis of primary lung cancer stage I, stage IIA or precancerous lesions; no chest pain before surgery Patients with chest pain; age 18 or older; voluntary participation in clinical trials, signed informed consent, and can be followed up.

Exclusion Criteria

Meet the diagnostic criteria of primary bronchogenic lung cancer, but have been treated by radiotherapy, chemotherapy, targeted therapy, Chinese medicine; patients with mental illness such as unconsciousness and communication difficulties; combined with severe heart, liver, kidney, brain Patients with vascular disease; patients with pregnancy planning, pregnancy, lactation; clinical data are incomplete.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
RS digital rating scale;
Secondary Outcome Measures
NameTimeMethod
EORTC QLQ-C30 (version 3) Quality of Life Questionnaire;
© Copyright 2025. All Rights Reserved by MedPath